BOLDRINI, LAURA
 Distribuzione geografica
Continente #
NA - Nord America 8.044
AS - Asia 3.630
EU - Europa 2.420
SA - Sud America 601
AF - Africa 177
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.881
Nazione #
US - Stati Uniti d'America 7.850
SG - Singapore 1.222
CN - Cina 1.124
IT - Italia 652
HK - Hong Kong 559
BR - Brasile 539
SE - Svezia 449
DE - Germania 332
BG - Bulgaria 253
VN - Vietnam 185
GB - Regno Unito 170
TR - Turchia 168
CA - Canada 159
FI - Finlandia 125
RU - Federazione Russa 110
KR - Corea 99
UA - Ucraina 82
CI - Costa d'Avorio 68
IN - India 66
FR - Francia 56
AT - Austria 53
SN - Senegal 36
BD - Bangladesh 33
CH - Svizzera 29
IQ - Iraq 28
JP - Giappone 27
AR - Argentina 22
BE - Belgio 21
MX - Messico 20
NL - Olanda 20
PL - Polonia 19
ZA - Sudafrica 18
UZ - Uzbekistan 17
ID - Indonesia 14
NG - Nigeria 13
ES - Italia 12
PK - Pakistan 12
IE - Irlanda 9
JO - Giordania 9
MA - Marocco 9
SA - Arabia Saudita 9
VE - Venezuela 9
AU - Australia 8
CO - Colombia 8
EG - Egitto 8
LT - Lituania 6
AZ - Azerbaigian 5
EC - Ecuador 5
IL - Israele 5
KZ - Kazakistan 5
PY - Paraguay 5
TN - Tunisia 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
CZ - Repubblica Ceca 4
KE - Kenya 4
LB - Libano 4
NP - Nepal 4
PH - Filippine 4
DZ - Algeria 3
GY - Guiana 3
HU - Ungheria 3
NI - Nicaragua 3
OM - Oman 3
PS - Palestinian Territory 3
RO - Romania 3
ZW - Zimbabwe 3
AL - Albania 2
BB - Barbados 2
BH - Bahrain 2
BJ - Benin 2
BN - Brunei Darussalam 2
CG - Congo 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
IR - Iran 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MD - Moldavia 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
BS - Bahamas 1
BW - Botswana 1
DK - Danimarca 1
EE - Estonia 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
KG - Kirghizistan 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
NA - Namibia 1
Totale 14.874
Città #
Ashburn 906
Fairfield 735
Singapore 664
Woodbridge 587
Chandler 574
Hong Kong 553
Dallas 525
Santa Clara 501
Ann Arbor 466
Houston 433
Seattle 298
San Jose 259
Sofia 253
Beijing 252
Cambridge 248
Wilmington 248
Shanghai 231
New York 188
Boardman 126
Ottawa 126
Princeton 111
Hefei 109
Izmir 106
Jacksonville 105
Pisa 105
Lawrence 101
Medford 95
Milan 93
Seoul 93
Los Angeles 91
Nanjing 91
Serra 88
Des Moines 70
Florence 69
Abidjan 68
São Paulo 56
Istanbul 45
Frankfurt am Main 44
Munich 43
The Dalles 42
Columbus 41
Buffalo 40
Vienna 39
Dakar 36
Dong Ket 36
San Diego 36
Boulder 35
Dearborn 33
Redondo Beach 33
Council Bluffs 32
Nanchang 32
Ogden 29
Bremen 28
Kunming 27
Chicago 25
Bern 24
London 23
Tokyo 23
Falls Church 22
Shenyang 22
Hanoi 21
Lancaster 21
Turku 20
Brussels 19
Hebei 19
Guangzhou 18
Ho Chi Minh City 17
Jüchen 17
Phoenix 17
Rio de Janeiro 17
Fuzhou 16
Redwood City 16
Rome 16
Tashkent 16
Baghdad 15
Helsinki 15
Warsaw 15
Changsha 14
Pune 14
Düsseldorf 13
Belo Horizonte 12
Cascina 12
Hangzhou 12
Toronto 12
Johannesburg 11
Lagos 11
Nuremberg 11
Nürnberg 11
Washington 11
Porto Alegre 10
Seacroft 10
Amman 9
Auburn Hills 9
Jiaxing 9
Jinan 9
Boston 8
Dhaka 8
Guarulhos 8
Norwalk 8
San Francisco 8
Totale 10.949
Nome #
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines 236
Evaluation of telomerase in the development and progression of colon cancer. Int J Mol Med. 2002 Nov;10(5):589-92 205
Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance 205
EZH2 Expression in Intestinal Neuroendocrine Tumors 201
C-MYC, HIF-1α, ERG, TKT, and GSTP1: an Axis in Prostate Cancer? 198
Lung recurrence of papillary thyroid cancer diagnosed with antithyroglobulin antibodies after 10 years from initial treatment. 195
EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center 194
Proposal for a New Diagnostic Histopathological Approach in the Evaluation of Ki-67 in GEP-NETs 193
Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features 187
Distinct Angiogenic microRNA-mRNA Expression Profiles Among Subtypes of Lung Adenocarcinoma. 185
Targeting of O6-methylguanine-DNA methyltransferase (MGMT) activity by antimessenger oligonucleotide sensitizes CHO/mex+ transfected cells to Mitozolomide 183
A high vascular count and overexpression of Vascular Endothelial Growth Factor (VEGF) are associated with unfavorable prognosis in operated Small Cell Carcinoma (SCLC) 180
Mutations of Fas (APO-1/CD95) and p53 genes in nonmelanoma skin cancer 179
Analysis of Fusion Genes by NanoString System: A Role in Lung Cytology? 177
Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study 175
Alterations of Fas (APO-1/CD95) gene and its relationship with p53 in non small cell lung cancer 172
3T3 NIH murine fibroblasts and B78 murine melanoma cells expressing the "E. coli" N3-methyladenine-DNA glycosylase I do not become resistant to alkylating agents" 171
Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression 171
CD34 microvessel density and VEGF expression in basal and squamous cell carcinoma 171
Effect of type I interferon(s) on cell viability and apoptosis in primary human thyrocyte cultures. 169
Differential microRNA expression profiles between young and old lung adenocarcinoma patients. 167
Neoangiogenesis as prognostic indicator of survival in lung cancer. 166
P2X7 protein expression and polymorphism in non-small cell lung cancer (NSCLC). 164
Anaplastic lymphoma kinase gene rearrangements in cytological samples of non-small cell lung cancer: comparison with histological assessment. 164
Evaluation of telomerase in non-melanoma skin cancer 161
Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancer 160
Management of peritoneal carcinomatosis with cytoreductive surgery combined with intraperitoneal chemohyperthermia at a novel italian center 160
Inherited germline T790M mutation and somatic epidermal growth factor receptor mutations in non-small cell lung cancer patients 157
Primary small cell carcinoma of the ureter: Case report and review of the literature 156
Immunohistochemical and molecular study of radiation-induced multiple meningiomas with pleural and pulmonary metastasis 155
Expression Profiling of LKB1 Pathway in Young and Old Lung Adenocarcinoma Patients. 155
Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction 154
VALUTAZIONE DELL'ATTIVITA' TELOMERASICA E DELL'ESPRESSIONE DI hTERT mRNA IN ADENOCARCINOMA DEL COLON 153
Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations 153
Quantitation of in vitro activity of synthetic trans-acting ribozyme using HPLC 150
A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma 149
COINVOLGIMENTO DEL SISTEMA FAS(CD95/APO-1)/FAS LIGANDO NEL PROCESSO DI APOPTOSI p53-MEDIATO IN ADENOCARCINOMI DEL COLON 148
Expression profiling and microRNA regulation of the LKB1 pathway in young and aged lung adenocarcinoma patients 147
Expression and function of P2X7 receptor in papillary thyroid cancer: a new potential marker of the disease? 146
The genotoxicity of the chlroethylating agent Mitozolomide is enhanced in CHO MEX+ cells by the administration of antimessenger oligonucleotide targeted against Methylguanine-DNA methyltransferase gene (MGMT) 145
Effect of Interferon-α and β on FAS mediated apoptosis and IL-6 release in Human primary thyrocytes 145
Regulation of telomerase and its hTERT messenger in colorectal cancer 140
null 138
Alterazioni del gene Fas (APO-1/CD95) nei carcinomi polmonari non a piccole cellule (NSCLC). Correlazioni con le alterazioni del gene P53. 136
Evaluation of telomerase mRNA (hTERT) in colon cancer 135
Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction 133
Differential microRNA Expression Profile between Young and Old Lung Adenocarcinoma Patients. 133
Intraductal prostate cancer: An aggressive subset of prostate cancers? Immunophenotypic evaluation 133
Alterations of Fas (APO-1/CD95) gene and its relationship with p53 in non small cell lung cancer 131
Gastrin-Releasing Peptide Receptor in Low Grade Prostate Cancer: Can It Be a Better Predictor Than Prostate-Specific Membrane Antigen? 131
Delta N133p53 Expression Levels in Relation to Haplotypes of the TP53 Internal Promoter Region 130
null 130
Osteopontin expression and prognostic significance in non-small cell lung cancer 129
Expression of p-AKT and p-mTOR in a large series of bronchopulmonary neuroendocrine tumors 129
The administration of gefitinib in patients with advanced non-small-cell lung cancer after the failure of erlotinib 128
Role of microRNA-33a in regulating the expression of PD-1 in lung adenocarcinoma. 126
Meningioma-associated brain oedema: the role of angiogenic factors and pial blood supply 125
The role of somatostatin in vasogenic meningioma associated brain edema 124
Telomerase in intracranial meningiomas 124
Neoangiogenesis in colon cancer: Correlation between vascular density, vascular endothelial growth factor (VEGF) and p53 protein expression 124
p16 and its putative interplay with metabolic factors in prostate cancer: An analysis based on public TCGA data 124
Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance 123
Vascular endothelial growth factor is associated with neovascularization and influences progression in Non Small Cell Lung Carcinoma (NSCLC). Clin Cancer Research 3: 861-865, 1997 122
Quantitation by competitive PCR assay of vascular endothelial growth factor (VEGF) in non-small cell lung carcinomas 122
Unusual Case of Pancreatic Adenocarcinoma with Bladder Metastasis 122
Thymidylate synthase, dihydropyrimidine dehydrogenase and thymidine phosphorylase expression in colorectal cancer and normal mucosa in patients 116
Tumor necrosis factor/a and trasforming growth/b are significantly associated with better prognosisi in non small cell lung carcinoma: putative relation with bcl-32-mediated neovascularization 116
null 116
WSB1 Involvement in Prostate Cancer Progression 114
Are Renal Cell Carcinoma with Fibromyomatous Stroma (RCC-FMS) and Thyroid-like Follicular Carcinoma of the Kidney (TLFCK) Really Independent Variants? 113
Multi-dimensional scaling analysis of key regulatory genes in prostate cancer using the tcga database 113
NEOANGIOGENESI IN ADENOCARCINOMI DEL COLON 112
null 111
Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas 110
Modulation of neoangiogenesis in bronchial preneoplastic lesions 107
Vascular endothelial growth factor is associated with neovascularization and influences progression in Non Small Cell lung Carcinoma (NSCLC) 105
Mutational analysis in cytological specimens of advanced lung adenocarcinoma: A sensitive method for molecular diagnosis 105
Prognostic role of TPL2 in early‑stage non‑small cell lung cancer 105
Interferon Beta induces IL-6 release but not apoptosis in primary cultures of human thyrocytes 104
Bel2 and p53 regulate vascular endothelial growth factor(VEGF)-mediated angiogenesis in non-small cell lung carcinoma. 104
Telomerase activity and hTERT mRNA expression in gliomas 104
TSP1 and TSP2 mRNA expression in lung carcinoma: relation with p53 alterations, angiogenic growth factors and vascular density 101
Expression of miRNA-25 in young and old lung adenocarcinoma 99
null 98
Steroid Hormones as Modulators of Emotional Regulation in Male Urogenital Cancers 97
Polymorphisms within inflammatory genes and colorectal cancer 97
Role of endothelin-1 in angiogenic phenomenon in intracranial meningiomas 94
Response to erlotinib in a patient with lung adenocarcinoma harbouring the EML4-ALK translocation: A case report. 94
Non-small-cell lung cancer in women: Clinical and molecular aspects 93
Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization 92
Epidermal growth factor receptor and K-RAS mutations in 411 lung adenocarcinoma: A population-based prospective study 90
Expression of cyclooxygenase-2 and its correlation with vasogenic brain edema in human intracranial meningiomas 86
Regulation of telomerase and its hTERT messenger in colorectal cancer 85
Prognostic significance of osteopontin expression in early-stage non-small-cell lung cancer 84
PLLA/Gelatine Spongy Matrices for the Regeneration of Bone Tissue 83
Expression of endothelia-1 is related to poor prognosis in non-small cell lung carcinoma Anno 2005 Titolo della Rivista Titolo EUROPEAN JOURNAL OF CANCER ISSN 0959-8049 83
null 83
Non-small-cell lung cancer in women: Clinical and molecular aspects 82
Expression of endothelin-1 (ET-1) and cyclooxygenase-2 (COX-2) in intracranial meningiomas 79
Thrombospondins I and II messenger RNA expression in lung carcinoma: Relationship with p53 alterations, angiogenic growth factors, and vascular density 77
Totale 13.546
Categoria #
all - tutte 43.367
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.367


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021430 0 0 0 0 0 0 40 64 80 45 47 154
2021/20221.260 10 83 55 75 272 190 39 74 50 36 46 330
2022/20231.554 171 173 112 166 166 221 5 125 292 5 111 7
2023/2024925 86 78 126 34 137 194 32 44 17 14 60 103
2024/20253.650 29 127 24 213 394 443 325 190 346 458 380 721
2025/20262.668 296 505 567 229 429 328 314 0 0 0 0 0
Totale 15.078